Penglihatan Buatan untuk Glaucoma Stadium Akhir: Prostesis Retina vs. Kortikal
Penglihatan Buatan untuk Glaucoma Stadium Akhir: Prostesis Retina vs. Kortikal Glaucoma stadium lanjut merusak saraf optik dan sel ganglion retina (RG...
بحث عميق وأدلة خبراء حول الحفاظ على صحتك البصرية.
Penglihatan Buatan untuk Glaucoma Stadium Akhir: Prostesis Retina vs. Kortikal Glaucoma stadium lanjut merusak saraf optik dan sel ganglion retina (RG...
İleri Evre Glokomda Yapay Görme: Retinal ve Kortikal Protezler İleri glokom optik sinir ve retinal ganglion hücrelerini (RGH'ler) yok ederek hastaları...
Sztuczne widzenie w zaawansowanej jaskrze: Protezy siatkówkowe a korowe Zaawansowana jaskra niszczy nerw wzrokowy i komórki zwojowe siatkówki (RGC), p...
Umělé vidění pro pokročilé stadium glaukomu: Sítnicové vs. kortikální protézy Pokročilý glaukom ničí zrakový nerv a retinální gangliové buňky (RGC), c...
Visão Artificial para Glaucoma em Estágio Avançado: Próteses Retinianas vs. Corticais O glaucoma avançado destrói o nervo óptico e as células ganglion...
Dirbtinė rega esant galutinės stadijos glaukomai: tinklainės ir žievės protezai Išsivysčiusi glaukoma sunaikina regos nervą ir tinklainės ganglijų ląs...
Искусственное зрение при терминальной глаукоме: ретинальные против кортикальных протезов Прогрессирующая глаукома разрушает зрительный нерв и ганглиоз...
晚期青光眼的仿生视觉:视网膜假体与皮层假体比较 晚期青光眼会杀死视神经和视网膜神经节细胞(RGCs),导致患者失明。仿生视觉(视觉假体)旨在绕过此类损伤。大多数现有假体针对视网膜或视神经,但在晚期青光眼患者中,这些通路已经消失。因此,研究人员正在探索直接刺激视觉皮层(大脑)的植入物。本文比较了用于青...
Artificial Vision for End-Stage Glaucoma: Retinal vs. Cortical Prostheses Advanced glaucoma kills the optic nerve and retinal ganglion cells (RGCs), l...
Argus II is a specific retinal implant system developed to give people with severe retinal degeneration a form of artificial vision by electrically stimulating the remaining retinal cells. The system uses a small array of electrodes that is implanted on the surface of the retina, together with glasses housing a camera and a processing unit that converts visual information into electrical pulses. When worn and activated, the device produces patterns of light perception that recipients can learn to interpret as edges, motion, or basic shapes, which can help with navigation and object detection. The experience is not like natural sight; it provides low-resolution, high-contrast signals that require training and rehabilitation to be useful in daily life. Argus II was one of the first retinal prosthesis systems to be used widely in clinical settings and to receive regulatory approvals, which helped establish standards for safety and effectiveness in the field. Users report benefits such as improved orientation, easier mobility, and greater independence, though outcomes vary across individuals. Surgical implantation carries risks, and the system has limitations in image detail, update speed, and long-term electrode performance. Despite these limits, Argus II represented an important milestone that encouraged further research and development in devices aiming to restore vision. Ongoing work builds on lessons from Argus II to improve resolution, biocompatibility, and the range of people who might benefit.